Confronting the 4th Wave of the Drug Overdose Death Crisis | Breakthroughs Can't Wait
Opioid and cocaine use epidemic is entrenched within Baltimore city, and there are no FDA-approved treatment for any stimulant disorders.At the University of Maryland, Baltimore, researchers are exploring how GLP-1 receptor agonists — a class of drugs commonly used for weight loss — may offer new hope for people with cocaine use disorder. This is just one example of how federally funded research at UMB is Changing The Future Today.Hear from Sarah Kattakuzhy, MD, co-director for the Research Initiative on Infectious Disease and Substance Use Disorder, at the University of Maryland School of Medicine explains. Kattakuzhy is also the associate director of the Kahlert Institute for Addiction Medicine.🧪 Breakthroughs Can’t Wait: UMB research drives innovation, improves lives, and tackles global challenges. But we can’t do it without continued support.🔗 Learn more and support research that saves lives: https://www.umaryland.edu/breakthroughs #BreakthroughsCantWait #NIHfunding #CocaineUseDisorder #GLP1 #AddictionResearch #UMB #ResearchMatters
More from Youtube
- 4:50How Can We Keep Young Drivers — and Others — Safe? | Breakthroughs Can't WaitEvery year, thousands of young lives are lost on U.S. roads.For Kerri McGowan Lowrey, JD, MPH, that’s not just a statistic. It’s also a public health crisis that calls for data-driven solutions.As deputy director of the Network for Public Health Law’s Eastern Region office at the University of Maryland Francis King Carey School of Law, Lowrey partnered with the National Highway Traffic Safety Administration to examine how driver licensing laws impact teen safety. Her team applied a method known as legal epidemiology — quantifying laws so researchers can evaluate their real-world effects on health and safety.Learn more at https://www.umaryland.edu/breakthroughs#TrafficSafety #DriverPolicy #NHTSA #PublicHealth #SmartDriving #BreakthroughsCantWaitUMB
- 0:55Smarter Driver Training for Safer Roads | Breakthroughs Can't WaitSmarter drivers make safer roads.Researchers at the University of Maryland, Baltimore are helping improve how drivers learn — using data, technology, and behavioral science.This research at Maryland Carey Law is supported by the National Highway Traffic Safety Administration (NHTSA).#RoadSafety #DriverTraining #NHTSA #TrafficSafety #BehavioralScience #BreakthroughsCantWaitUMB
- 0:35New Cancer Treatment: Ultrasound Opens the Brain to ChemoOnly 2% of cancer drugs can reach the brain — but that could change.At UMB, researchers use focused ultrasound before and after brain tumor surgery to open the blood-brain barrier, helping chemo reach where it couldn’t before.Supported by the National Cancer Institute and the National Institute of Neurological Disorders and Stroke, both within the NIH.#CancerResearch #BrainTumor #NIH #FocusedUltrasound #NCI #NINDS #BreakthroughsCantWaitUMB
- 0:54Breakthrough Therapy: Opening the Blood-Brain BarrierAt the University of Maryland, Baltimore, researchers are breaking through one of medicine’s greatest challenges: safely opening the blood-brain barrier to deliver therapies.This breakthrough — supported by the National Cancer Institute and the National Institute of Neurological Disorders and Stroke at the NIH — could transform treatment for brain tumors and neurological diseases.#BrainResearch #BloodBrainBarrier #NIH #NCI #NINDS #MedicalBreakthrough #BreakthroughsCantWaitUMB
- 1:01Focused Ultrasound Enhances Brain Tumor TreatmentCan we treat brain tumors with ultrasound waves?Researchers at the University of Maryland are making it possible — with a new drug delivery method that targets brain tumors directly.This research is supported by the National Cancer Institute and the National Institute of Neurological Disorders and Stroke, both part of the NIH.#BrainTumor #CancerResearch #NIH #NCI #NINDS #MedicalBreakthrough
- 5:00Could Focused Ultrasound Transform Brain Cancer Treatment? | Breakthroughs Can't WaitDr. Graeme Woodworth is opening the door to a promising new treatment for aggressive malignant brain cancer.Focused ultrasound activating bubbles in the blood allow targeted chemotherapy to cross the blood-brain barrier.Graeme F. Woodworth, MD, FACS, chief of neurosurgery at the University of Maryland Medical Center and the Howard M. Eisenberg, MD Distinguished Professor of Neurosurgery and chair of the Department of Neurosurgery at the University of Maryland School of Medicine, is advancing the treatment of glioblastoma, the most common and deadly primary brain cancer in adults. More than 14,000 Americans are diagnosed with glioblastoma each year. Patients typically survive only 12 to18 months after a diagnosis because the cancer quickly spreads throughout the brain.His research is funded by grants from the National Cancer Institute and the National Institute of Neurological Disorders and Stroke, both within the National Institutes of Health.Learn more: https://www.umaryland.edul/breakthroughs#CancerResearch #braincancer #nihresearch #NIH #NINDS #medicalbreakthrough
